About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Experience Knolens
Hemogenyx Pharmaceuticals Expands Pediatric R/R AML Trial for HG-CT-1 CAR-T Therapy
Hemogenyx Pharmaceuticals plc announced a protocol amendment to include pediatric patients with relapsed/refractory acute myeloid leukemia (R/R AML) i...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
Hemogenyx Pharmaceuticals Expands Pediatric R/R AML Trial for HG-CT-1 CAR-T Therapy